Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms. - Wikidata - wikimedia - TriplyDB

Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.

Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.

http://www.wikidata.org/entity/Q35144523

about

Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment.Braf mutation in interdigitating dendritic cell sarcoma: a case report and review of the literature.Treatment of breast cancer 2 (BRCA2)-mutant follicular dendritic cell sarcoma with a poly ADP-ribose polymerase (PARP) inhibitor: a case report.Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.Bone pathologic fracture revealing an unusual association: coexistence of Langerhans cell histiocytosis with Rosai-Dorfman disease.A Case of Cutaneous Rosai-Dorfman Disease with underlying calvarial involvement and absence of BRAF(V600E) mutation.Head and Neck Extranodal Interdigitating Dendritic Cell Sarcoma: Case Report and Review of the Literature.The 2016 revision of the World Health Organization classification of lymphoid neoplasms.Clinicopathological features and BRAFV600E mutations in patients with isolated hypothalamic-pituitary Langerhans cell histiocytosis.Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.Histiocytic sarcoma: New insights into FNA cytomorphology and molecular characteristics.Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.Intrathoracic Rosai Dorfman Disease with Focal Aggregates of IgG4-bearing Plasma Cells. Case Report and Literature Review.Histiocytic neoplasms in the era of personalized genomic medicine.Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.A Case of Pulmonary Langerhans Cell Sarcoma Simultaneously Diagnosed with Cutaneous Langerhans Cell Histiocytosis Studied by Whole-Exome Sequencing.Identification and Targeting of Kinase Alterations in Histiocytic Neoplasms.Cooperation of BRAF(F595L) and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling.Sustained response to salvage therapy for dabrafenib-resistant metastatic Langerhans cell sarcoma.BRAF V600E expression in histiocytic sarcoma associated with splenic marginal zone lymphoma: a case report.Rosai-Dorfman Disease Harboring an Activating KRAS K117N Missense Mutation.Genetic homogeneity of adult Langerhans cell histiocytosis lesions: Insights from BRAFV600E mutations in adult populations.Canine Histiocytic Malignancies-Challenges and Opportunities.Prognostic factors for histiocytic and dendritic cell neoplasms.Genomic analysis of follicular dendritic cell sarcoma by molecular inversion probe array reveals tumor suppressor-driven biology.Gain-of-function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs.Pediatric intracerebral histiocytic sarcoma with rhabdoid features: Case report and literature review.The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis."Medusa-Head" cells, "Starfish" cells, and interconnecting long cytoplasmic processes as diagnostic cytologic clues for follicular dendritic cell sarcoma in fine needle aspiration samples.Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma.Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing.Expression of enhancer of zeste homolog 2 (EZH2) protein in histiocytic and dendritic cell neoplasms with evidence for p-ERK1/2-related, but not MYC- or p-STAT3-related cell signaling.Somatic mutations in histiocytic sarcoma identified by next generation sequencing.Fine needle aspiration cytology of histiocytic sarcoma with dendritic cell differentiation: a case of transdifferentiation from low-grade follicular lymphoma.Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors.Targeted genomic sequencing of follicular dendritic cell sarcoma reveals recurrent alterations in NF-κB regulatory genes.Intracranial Interdigitating Dendritic Cell Sarcoma: First Case Report.[Tumors of dendritic and other accessory cells of lymph nodes].BRAF V600E mutation-specific immunohistochemistry is a rare finding in dendritic cell- and histiocyte-derived tumors.

P2860

Q30251765-61F9623C-3904-4F1F-81A1-3DF77D973D21 Q30966783-25186A55-BBB2-4BF1-B06D-4991C6168ACD Q36094171-B8EB70C1-F0E9-4A9A-8C95-08EB04E7A422 Q36260647-AB017CCD-A600-4651-84F1-FD7CDC23538C Q36342646-E79A36CB-8326-4695-A358-5691E688F806 Q36549478-AA0592DD-7B71-4435-ABF9-F3DAF39F3F92 Q36819922-D19CAFF3-2C40-4638-B7C6-ABBB76CF9CA2 Q36920426-E716A19E-549F-4AEE-800B-951FBD9FCD46 Q37350433-B970E83F-BA20-46D3-864C-E40852AC9889 Q37509422-0DD4B331-32F5-437B-ACD3-FC330C3E1891 Q38625994-CC6CF34A-4089-4107-AA00-25087A344D42 Q38700671-5B068CE5-EB15-4964-B82B-70E12B47C225 Q38714948-8E0C1BDC-39E2-4366-9882-ACBCE0141A9B Q38814135-B84942BE-FB03-42C0-A957-974A26C08E38 Q38992646-91394FAE-C59A-4745-B742-51FB406638B5 Q39373752-2AAE1242-4E89-4E4E-9316-59C4242C030E Q39411958-6CFB4947-B716-4D5B-B986-520B7CB3DAAB Q40305624-D4BD614C-37B6-4C8B-BAD8-A1C2DDD423EC Q40630478-7907783D-3E23-4C09-8ABA-3F028E305450 Q42064963-4269784C-6A8F-47FE-B3B7-45282AE984A2 Q42127711-882E97DD-BF4C-47BC-8E8F-68B6DCB10CD6 Q44195415-29EE80A3-E633-49AD-86C9-5CF4A62115CD Q44876356-98DBF638-800B-4A48-9263-2C8730AC3282 Q47094254-CA7909A0-B1DB-452A-9185-2282C35851BF Q47573861-E245EF8A-9119-479A-BCBF-C07A7E778BEA Q47955988-8EC9B82A-B5D1-4BD6-B8BB-89A591C9F28B Q48022774-D7362ABE-ED16-4EC1-B073-A99973548E3D Q48217203-EA96E8EC-9544-4314-B998-956D4D4DF914 Q48276855-02888E9F-52C1-4F7F-9C2B-E744EB18D5CC Q49224924-A59DE717-05D4-4647-8B3F-29A41780F6E6 Q49795179-AEA6E8E9-088A-47F2-B9F9-576F77DC3C75 Q50071606-67089116-541B-412E-8940-1DFB831E483D Q50891287-439CF5E3-2D85-4792-99CC-8AE128CAB0EB Q51023220-EBE44FD5-9EAF-4026-9AA4-6503797EFBD6 Q51829348-6294AC63-1D2E-4747-9020-9B5571DFEB1F Q52640415-3C67F09E-B80A-4D1E-8B41-54C5D0E8F2D0 Q52902946-B13CEDD3-BC16-42D2-A583-699DD8F76408 Q52926811-F39222C5-471E-46BA-8B80-BD0ACC3C89BB Q53214605-DD73F8B6-3B71-40ED-B533-5CCD16B3A03A Q54320679-DEFE9BC7-6612-47DC-9B93-3F53F7CCEC6F

P2860

Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.

http://www.wikidata.org/entity/Q35144523

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.

@ast

Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.

@en

type

label

Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.

@ast

Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.

@en

prefLabel

Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.

@ast

Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.

@en

P1433

Q35144523-586CD7EC-24EA-4F7D-B121-6CFB7B1CE792

P1476

Q35144523-E2E835EE-CCBB-4948-880F-2BE29D8B1BCE

P2093

Q35144523-3A91A98C-3FF5-45DD-9386-29446CC82A42

Q35144523-8CF00EA1-D874-45DE-B550-524BAEC3B846

Q35144523-A74B9380-030C-4AD3-9631-38897F23AD2F

Q35144523-B091F441-08AE-47A3-A331-39E14CA59EDE

Q35144523-B72CC9EB-235B-41ED-9982-ED08E26FB899

Q35144523-C5B5CA98-2D0B-485D-8D5C-DBC6E233AEC5

Q35144523-CBFE39DC-1350-4452-B2B9-7EA0370B76FC

Q35144523-CCF40BEC-B8CE-4D2F-B109-09D8F24300D8

Q35144523-D1271566-8060-4403-8A68-36236C11482B

Q35144523-E4006BF1-F616-4AAF-A2C9-4DE7F51D97DF

P2860

Q35144523-0A9D784F-82CB-4CE6-B8A1-3BEA69742CD2

Q35144523-24B4B70C-68D1-4BD5-AC3F-839148956C0F

Q35144523-3A88102B-2844-4B5A-BC99-582206BE3222

Q35144523-3C545712-A8C9-474A-9A99-F9035E646B20

Q35144523-416BB822-6E62-4A4E-869A-D10CB7A5289B

Q35144523-5A00FDA2-3649-448E-B213-5C8B0C0962FD

Q35144523-6BC69203-995E-4508-AB3D-DE9078AAD6FC

Q35144523-6C928B96-7311-4851-8873-97725D354ED0

Q35144523-7AA19A45-928E-4E1B-AC9F-444E08ECB487

Q35144523-7E3B3B6C-5F2C-4138-B91D-9110F2812E3B

P304

Q35144523-8399962C-B0EE-4F46-9F63-14C01D23D685

P31

Q35144523-F34687AD-1B1D-4A80-BBDD-523A700F5B0E

P356

Q35144523-FC526B0A-3014-4153-AB46-A26D3A241CE9

P433

Q35144523-CDB2D5B1-895A-40A9-9BB2-5DC933F84FF1

P478

Q35144523-F435AF7D-D7EB-4DE9-873E-4C9B7EF6D3C1

P577

Q35144523-89211D05-9A75-4956-BE8D-A1A9F33AF1C4

P698

Q35144523-4C31D011-D484-4269-9C26-67D0812263ED

P356

P1433

P1476

Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.

@en

P2093

Gyeongsin Park

http://www.w3.org/2001/XMLSchema#string

Hee Jeong Cha

http://www.w3.org/2001/XMLSchema#string

Heounjeong Go

http://www.w3.org/2001/XMLSchema#string

Hyun-Jung Kim

http://www.w3.org/2001/XMLSchema#string

Ji Eun Kim

http://www.w3.org/2001/XMLSchema#string

Jooryung Huh

http://www.w3.org/2001/XMLSchema#string

Sookee Min

http://www.w3.org/2001/XMLSchema#string

Suk Jin Choi

http://www.w3.org/2001/XMLSchema#string

Yoo-Duk Choi

http://www.w3.org/2001/XMLSchema#string

Yoon Kyung Jeon

http://www.w3.org/2001/XMLSchema#string

P2860

Blood monocytes: development, heterogeneity, and relationship with dendritic cells

Recurrent BRAF mutations in Langerhans cell histiocytosis

BRAF mutations in hairy-cell leukemia

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

Recent advances in the understanding of Langerhans cell histiocytosis

Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation

Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.

BRAF(E600) in benign and malignant human tumours.

Langerhans cell histiocytosis and Erdheim-Chester disease.

EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.

P304

261-272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HIS.12416

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24720374

http://www.w3.org/2001/XMLSchema#string